Filing Details
- Accession Number:
- 0001209191-12-037971
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-12 20:34:59
- Reporting Period:
- 2012-07-10
- Filing Date:
- 2012-07-12
- Accepted Time:
- 2012-07-12 19:34:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1282660 | R Julianna Wood | C/O Onyx Pharmaceuticals, Inc. 249 East Grand Ave. South San Francisco CA 94080 | Vp, Public Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-07-10 | 1,321 | $28.55 | 25,035 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-07-10 | 1,531 | $30.28 | 26,566 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-07-10 | 2,852 | $68.01 | 23,714 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-07-10 | 1,321 | $0.00 | 1,321 | $28.55 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-07-10 | 1,531 | $0.00 | 1,531 | $30.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,561 | 2019-03-31 | No | 4 | M | Direct | |
| 10,719 | 2020-03-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 200 | Indirect | Childrens' Trust |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- 12.5% of the shares subject to the option became exercisable 6 months following the date of grant. The remaining shares became exercisable in equal monthly installments over the following 42 months for a total vesting schedule of 48 months.
Billionaire Hedge Funds
